XbiotechXBIT
13F holders, Q1 2024 (March 31)46holders
2famous investors
$8.13avg. 13F price*
At the end of Q1 2024, 46 institutions reported holding Xbiotech Inc. (XBIT) in their 13F filings. The largest holders were Millennium Management ($7.5M), Vanguard Group Inc. ($7.3M) and BlackRock Inc. ($2.5M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Xbiotech Inc.
- CUSIP
- 98400H102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $2.1M |
| Exits | 3 | $349K |
Ownership 46 holders
| Millennium Management | 0.01% | Add +16.5% | 927,368 | $7.5M |
| Vanguard Group Inc. | 0.00% | Add +1.6% | 895,315 | $7.3M |
| BlackRock Inc. | 0.00% | Add +10.2% | 306,624 | $2.5M |
| Credit Suisse AG/ | 0.00% | No change | 248,270 | $2.0M |
| Geode Capital Management, LLC | 0.00% | Add +1.4% | 195,204 | $1.6M |
| Susquehanna International Group, LLP | 0.00% | Add +353.5% | 169,812 | $1.4M |
| Bridgeway Capital Management, LLC | 0.02% | Add +3.3% | 149,318 | $1.2M |
| Morgan Stanley | 0.00% | Add +5.3% | 116,327 | $946K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Add +21.1% | 77,413 | $629K |
| Northern Trust Corp. | 0.00% | Reduce -4.6% | 75,389 | $613K |
| Dimensional Fund Advisors LP | 0.00% | No change | 72,475 | $589K |
| Qube Research & Technologies Ltd | 0.00% | Add +19.8% | 67,662 | $550K |
| Empowered Funds, LLC | 0.01% | Add +7.9% | 64,277 | $523K |
| Goldman Sachs Group Inc. | 0.00% | New | 62,161 | $505K |
| State Street Corp. | 0.00% | No change | 56,526 | $460K |
| Jane Street Group, LLC | 0.00% | Add +235.8% | 54,822 | $446K |
| Marshall Wace, LLP | 0.00% | New | 54,679 | $445K |
| Bank of New York Mellon Corp | 0.00% | Reduce -13.0% | 48,451 | $394K |
| Citigroup Inc. | 0.00% | Add +149.3% | 36,752 | $299K |
| HRT Financial LP | 0.00% | New | 33,593 | $273K |
| National Bank of Canada | 0.00% | Add +35.5% | 33,000 | $272K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.05% | New | 25,954 | $211K |
| Balyasny Asset Management L.P. | 0.00% | New | 21,865 | $178K |
| Brevan Howard Capital Management LP | 0.02% | New | 20,578 | $167K |
| FMR LLC | 0.00% | Reduce -0.4% | 19,966 | $162K |
| Two Sigma Advisers, LP | 0.00% | Reduce -23.2% | 18,433 | $150K |
| Y-Intercept (Hong Kong) Ltd | 0.01% | New | 18,043 | $147K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 17,600 | $144K |
| ExodusPoint Capital Management, LP | 0.00% | New | 16,177 | $132K |
| Thomasville National Bank | 0.01% | No change | 13,350 | $109K |
| BNP Paribas Financial Markets | 0.00% | Add +10.6% | 12,522 | $102K |
| Synovus Financial Corp. | 0.00% | No change | 11,796 | $96K |
| Two Sigma Investments, LP | 0.00% | Reduce -57.9% | 10,707 | $87K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 10,477 | $85K |
| Bank of America Corp. | 0.00% | Reduce -35.0% | 8,690 | $71K |
| UBS Group AG | 0.00% | Reduce -22.3% | 7,344 | $60K |
| Citadel Advisors | 0.00% | Reduce -42.6% | 7,042 | $57K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 5,254 | $43K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +2048.1% | 1,117 | $9K |
| McIlrath & Eck, LLC | 0.00% | No change | 753 | $6K |
| Rhumbline Advisers | 0.00% | No change | 753 | $6K |
| Wells Fargo & Company | 0.00% | Add +2.0% | 155 | $1K |
| Royal Bank of Canada | 0.00% | Reduce -65.6% | 99 | $1K |
| Simplex Trading, LLC | 0.00% | Reduce -63.6% | 228 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 38 | $309 |
| Macquarie Group Ltd. | 0.00% | New | 576 | $5 |
"% of holder's portfolio" is XBIT's weight in each manager's 13F, not the share of Xbiotech Inc. the manager owns.